Live Breaking News & Updates on Middle Market Healthcare

Stay updated with breaking news from Middle market healthcare. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Healthcare M&A Revs Up For Post-Covid Growth | Global Finance Magazine


Healthcare M&A Revs Up For Post-Covid Growth
Advertisement
M&A transactions globally increased 25% in the second half of 2020 from the first half and were up 14% year over year.
April 01, 2021
Bolt-on acquisitions of healthcare and pharma businesses will intensify this year as large companies refocus their core business and private equity funds target assets that grew faster during the pandemic.
Five mega deals totaling around $97 billion dollars gave a solid impulse to M&A last year. Among the top deals, AstraZeneca bought Alexion Pharmaceuticals, Gilead Sciences took over Immunomedics, and Bristol Myers acquired MyoKardia.
The number of global transactions increased 25% in the second half of 2020 from the first half and was up 14% year over year, according to estimates by PwC. The acceleration was driven by acquisitions of medical devices, biotech, and pharma in Asia, according to the PwC report Global M&A Industry Trends in Health Industries. ....

Republic Of , Beth Everett , Bristol Myers , Financial Group , Alexion Pharmaceuticals , Gilead Sciences , Mitsubishi Ufj , Industry Trends , Health Industries , Global Healthcare , Middle Market Healthcare , குடியரசு ஆஃப் , பெத் எவரெட் , பிரிஸ்டல் மைஸ் , நிதி குழு , அலெக்சியன் மருந்துகள் , கிலியட் அறிவியல் , மிட்‌ஸ்யூபீஶி உப்ஜு , தொழில் போக்குகள் , ஆரோக்கியம் தொழில்கள் , உலகளாவிய சுகாதாரம் , நடுத்தர சந்தை சுகாதாரம் ,